For 60-Plus Years, Respiratory Syncytial Virus (RSV) Vaccines Have Evaded Scientists. But Now That’s Changed [Sponsored]
This year health care providers have tools to help prevent lower respiratory tract disease caused by RSV for older adults.
This podcast was funded by GSK and produced for GSK by Scientific American Custom Media, a division separate from the magazine’s board of editors.